AI answer engines already summarize products, but catalogue evidence is rarely tested against how buying agents ask questions.
Head of Digital / Head of Commerce
Prepare for agentic buying without surrendering control.
Retail and e-commerce teams need product evidence, policy context, inventory truth, and agent-safe boundaries before AI assistants start shaping discovery, comparison, or checkout decisions.
- Score readiness firstPRISMFind the first deployment gap before a call.
- Inspect proofPHANTOMReplay the governed approval boundary.
- Verify evidenceEvidence roomChoose role and workflow proof.
- Build passportPassportPackage readiness signals into one artifact.
- Send ATLAS intakeRequestCarry context into founder review.
Buyer pain
The problem is not interest in AI. It is proof at the decision boundary.
Product, policy, inventory, delivery, and returns data live in different systems, which makes agent answers brittle.
Checkout, discount, refund, and customer-facing commitments need explicit deferral until approval gates and support ownership exist.
Governed approach
HARNEXA turns the buyer question into inspectable artifacts.
Start with Agent Visibility Optimisation: product facts, schema, prompt-panel answers, substitutes, compatibility, and recommendation evidence.
Map MCP, WebMCP, A2A, UCP, ACP, AP2, and x402 as readiness layers before exposing tools or transaction rails.
Keep checkout, refund, payment, discount, and order actions out of scope until identity, approval, audit, and support gates hold.
Evidence packet
What the buyer receives before the scope expands.
- AVO prompt-panel and catalogue evidence gap report
- Product, inventory, policy, and returns source map
- Protocol + AVO readiness memo
- PRISM readiness score with top-three gaps
- Commerce Readiness Passport for stakeholder review
Proof links
Inspect the working evidence, then carry context into ATLAS intake.
Next step
Start with the artifact this buyer will inspect first.
HARNEXA keeps the path narrow: one workflow, one buyer question, one evidence packet, and one founder-reviewed diagnostic or deployment path.